Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 3.067 | 4.07e-18 | 2.24e-05 | 3.84e-04 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
PXN | 5829 | 19 | -2.554 | 3.193 | 206 | Yes | Yes |
MS4A2 | 2206 | 2 | -2.182 | 3.067 | 9 | Yes | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
MVP | 9961 | 16 | -2.846 | 3.193 | 20 | Yes | Yes |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
[ SYK ] | 6850 | 2 | -1.934 | 3.067 | 115 | - | - |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
PXN | 5829 | MVP | 9961 | pp | -- | int.I2D: BIND |
PXN | 5829 | SYK | 6850 | pp | -- | int.I2D: BioGrid, BCI, HPRD; int.HPRD: in vitro, in vivo |
PXN | 5829 | SRSF3 | 6428 | pp | -- | int.I2D: BIND |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
HNRNPU | 3192 | SYK | 6850 | pp | -- | int.I2D: BCI, HPRD; int.HPRD: in vitro |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
MS4A2 | 2206 | SYK | 6850 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: in vitro, in vivo |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0043306 | positive regulation of mast cell degranulation | 1.24e-05 | 1.79e-01 | 8.476 | 2 | 2 | 9 |
GO:0019901 | protein kinase binding | 2.64e-05 | 3.81e-01 | 4.338 | 4 | 18 | 317 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 2.69e-05 | 3.88e-01 | 7.946 | 2 | 2 | 13 |
GO:0044212 | transcription regulatory region DNA binding | 1.24e-04 | 1.00e+00 | 4.839 | 3 | 17 | 168 |
GO:0005654 | nucleoplasm | 2.30e-04 | 1.00e+00 | 2.889 | 5 | 64 | 1082 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0032928 | regulation of superoxide anion generation | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0042991 | transcription factor import into nucleus | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0023057 | negative regulation of signaling | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0072376 | protein activation cascade | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0090237 | regulation of arachidonic acid secretion | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0051435 | BH4 domain binding | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0071226 | cellular response to molecule of fungal origin | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0008283 | cell proliferation | 8.84e-04 | 1.00e+00 | 3.874 | 3 | 14 | 328 |
GO:0007229 | integrin-mediated signaling pathway | 1.01e-03 | 1.00e+00 | 5.361 | 2 | 3 | 78 |
GO:0060242 | contact inhibition | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0032998 | Fc-epsilon receptor I complex | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0045401 | positive regulation of interleukin-3 biosynthetic process | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0043366 | beta selection | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0002366 | leukocyte activation involved in immune response | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0043313 | regulation of neutrophil degranulation | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0005178 | integrin binding | 1.53e-03 | 1.00e+00 | 5.061 | 2 | 4 | 96 |
GO:0002554 | serotonin secretion by platelet | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0002283 | neutrophil activation involved in immune response | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0019815 | B cell receptor complex | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0019767 | IgE receptor activity | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0030529 | ribonucleoprotein complex | 2.08e-03 | 1.00e+00 | 4.839 | 2 | 5 | 112 |
GO:0038127 | ERBB signaling pathway | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0010543 | regulation of platelet activation | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0090330 | regulation of platelet aggregation | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0032009 | early phagosome | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 2.87e-03 | 1.00e+00 | 4.602 | 2 | 4 | 132 |
GO:0001714 | endodermal cell fate specification | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0019863 | IgE binding | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 2 | 5 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0006974 | cellular response to DNA damage stimulus | 3.74e-03 | 1.00e+00 | 4.408 | 2 | 7 | 151 |
GO:0001945 | lymph vessel development | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 6 |
GO:0050764 | regulation of phagocytosis | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 6 |
GO:0002281 | macrophage activation involved in immune response | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 6 |
GO:0050663 | cytokine secretion | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 |
GO:0000398 | mRNA splicing, via spliceosome | 4.39e-03 | 1.00e+00 | 4.289 | 2 | 15 | 164 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 4.60e-03 | 1.00e+00 | 4.254 | 2 | 5 | 168 |
GO:0001955 | blood vessel maturation | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0007172 | signal complex assembly | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0060396 | growth hormone receptor signaling pathway | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0003714 | transcription corepressor activity | 5.15e-03 | 1.00e+00 | 4.170 | 2 | 11 | 178 |
GO:0005515 | protein binding | 5.23e-03 | 1.00e+00 | 1.090 | 8 | 198 | 6024 |
GO:0006983 | ER overload response | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0031953 | negative regulation of protein autophosphorylation | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0004716 | receptor signaling protein tyrosine kinase activity | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0046638 | positive regulation of alpha-beta T cell differentiation | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0005634 | nucleus | 5.94e-03 | 1.00e+00 | 1.299 | 7 | 159 | 4559 |
GO:0035413 | positive regulation of catenin import into nucleus | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 10 |
GO:0046641 | positive regulation of alpha-beta T cell proliferation | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 10 |
GO:0045579 | positive regulation of B cell differentiation | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 10 |
GO:0010467 | gene expression | 6.76e-03 | 1.00e+00 | 2.845 | 3 | 45 | 669 |
GO:0045780 | positive regulation of bone resorption | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 3 | 11 |
GO:0017166 | vinculin binding | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 |
GO:0033630 | positive regulation of cell adhesion mediated by integrin | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 4 | 11 |
GO:0035198 | miRNA binding | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0042101 | T cell receptor complex | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0019370 | leukotriene biosynthetic process | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0008380 | RNA splicing | 8.32e-03 | 1.00e+00 | 3.813 | 2 | 22 | 228 |
GO:0034614 | cellular response to reactive oxygen species | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 2 | 14 |
GO:0001824 | blastocyst development | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 2 | 15 |
GO:0008134 | transcription factor binding | 9.34e-03 | 1.00e+00 | 3.727 | 2 | 18 | 242 |
GO:0043274 | phospholipase binding | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 16 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 2 | 17 |
GO:0048514 | blood vessel morphogenesis | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 1 | 17 |
GO:0050850 | positive regulation of calcium-mediated signaling | 1.18e-02 | 1.00e+00 | 6.398 | 1 | 1 | 19 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 3 | 20 |
GO:0032757 | positive regulation of interleukin-8 production | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 20 |
GO:0005737 | cytoplasm | 1.25e-02 | 1.00e+00 | 1.352 | 6 | 124 | 3767 |
GO:0048041 | focal adhesion assembly | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 21 |
GO:0050715 | positive regulation of cytokine secretion | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 22 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 1 | 23 |
GO:0035329 | hippo signaling | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 5 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 26 |
GO:0048754 | branching morphogenesis of an epithelial tube | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 27 |
GO:0007159 | leukocyte cell-cell adhesion | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 27 |
GO:0002250 | adaptive immune response | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 28 |
GO:0005875 | microtubule associated complex | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 28 |
GO:0030032 | lamellipodium assembly | 1.80e-02 | 1.00e+00 | 5.788 | 1 | 1 | 29 |
GO:0050853 | B cell receptor signaling pathway | 1.80e-02 | 1.00e+00 | 5.788 | 1 | 2 | 29 |
GO:0003723 | RNA binding | 1.81e-02 | 1.00e+00 | 3.228 | 2 | 18 | 342 |
GO:0043565 | sequence-specific DNA binding | 1.85e-02 | 1.00e+00 | 3.212 | 2 | 11 | 346 |
GO:0042169 | SH2 domain binding | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 2 | 30 |
GO:0042594 | response to starvation | 1.92e-02 | 1.00e+00 | 5.692 | 1 | 4 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 32 |
GO:0051219 | phosphoprotein binding | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 32 |
GO:0006355 | regulation of transcription, DNA-templated | 2.02e-02 | 1.00e+00 | 2.270 | 3 | 43 | 997 |
GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 2 | 35 |
GO:0034446 | substrate adhesion-dependent cell spreading | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 2 | 36 |
GO:0007257 | activation of JUN kinase activity | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 5 | 36 |
GO:0044822 | poly(A) RNA binding | 2.35e-02 | 1.00e+00 | 2.187 | 3 | 50 | 1056 |
GO:0035019 | somatic stem cell maintenance | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 6 | 40 |
GO:0030593 | neutrophil chemotaxis | 2.53e-02 | 1.00e+00 | 5.289 | 1 | 2 | 41 |
GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 3 | 42 |
GO:0031124 | mRNA 3'-end processing | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 2 | 42 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.65e-02 | 1.00e+00 | 2.935 | 2 | 30 | 419 |
GO:0006369 | termination of RNA polymerase II transcription | 2.77e-02 | 1.00e+00 | 5.154 | 1 | 2 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 4 | 46 |
GO:0006986 | response to unfolded protein | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 1 | 51 |
GO:0051028 | mRNA transport | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 4 | 52 |
GO:0009611 | response to wounding | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 5 | 52 |
GO:0001725 | stress fiber | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 4 | 55 |
GO:0007202 | activation of phospholipase C activity | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 1 | 55 |
GO:0003677 | DNA binding | 3.43e-02 | 1.00e+00 | 1.981 | 3 | 49 | 1218 |
GO:0005643 | nuclear pore | 3.50e-02 | 1.00e+00 | 4.813 | 1 | 11 | 57 |
GO:0006396 | RNA processing | 3.62e-02 | 1.00e+00 | 4.764 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 3.62e-02 | 1.00e+00 | 4.764 | 1 | 6 | 59 |
GO:0008013 | beta-catenin binding | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 9 | 60 |
GO:0042742 | defense response to bacterium | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 5 | 60 |
GO:0006406 | mRNA export from nucleus | 3.74e-02 | 1.00e+00 | 4.715 | 1 | 4 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 3.74e-02 | 1.00e+00 | 4.715 | 1 | 2 | 61 |
GO:0019903 | protein phosphatase binding | 3.80e-02 | 1.00e+00 | 4.692 | 1 | 2 | 62 |
GO:0010468 | regulation of gene expression | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 2 | 68 |
GO:0034329 | cell junction assembly | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 3 | 68 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 2 | 74 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 4 | 74 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 4.59e-02 | 1.00e+00 | 4.417 | 1 | 2 | 75 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.59e-02 | 1.00e+00 | 4.417 | 1 | 1 | 75 |
GO:0071013 | catalytic step 2 spliceosome | 4.76e-02 | 1.00e+00 | 4.361 | 1 | 7 | 78 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 4.82e-02 | 1.00e+00 | 4.342 | 1 | 2 | 79 |
GO:0004713 | protein tyrosine kinase activity | 5.00e-02 | 1.00e+00 | 4.289 | 1 | 3 | 82 |
GO:0009653 | anatomical structure morphogenesis | 5.06e-02 | 1.00e+00 | 4.271 | 1 | 2 | 83 |
GO:0045087 | innate immune response | 5.06e-02 | 1.00e+00 | 2.427 | 2 | 15 | 596 |
GO:0009887 | organ morphogenesis | 5.24e-02 | 1.00e+00 | 4.220 | 1 | 5 | 86 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 5.24e-02 | 1.00e+00 | 4.220 | 1 | 8 | 86 |
GO:0006936 | muscle contraction | 5.30e-02 | 1.00e+00 | 4.203 | 1 | 3 | 87 |
GO:0005829 | cytosol | 5.42e-02 | 1.00e+00 | 1.361 | 4 | 86 | 2496 |
GO:0000187 | activation of MAPK activity | 5.48e-02 | 1.00e+00 | 4.154 | 1 | 3 | 90 |
GO:0007010 | cytoskeleton organization | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 4 | 91 |
GO:0006928 | cellular component movement | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 3 | 91 |
GO:0001649 | osteoblast differentiation | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 5 | 92 |
GO:0005770 | late endosome | 5.66e-02 | 1.00e+00 | 4.107 | 1 | 2 | 93 |
GO:0008360 | regulation of cell shape | 6.25e-02 | 1.00e+00 | 3.960 | 1 | 4 | 103 |
GO:0005938 | cell cortex | 6.31e-02 | 1.00e+00 | 3.946 | 1 | 5 | 104 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.73e-02 | 1.00e+00 | 2.197 | 2 | 39 | 699 |
GO:0007050 | cell cycle arrest | 7.48e-02 | 1.00e+00 | 3.692 | 1 | 5 | 124 |
GO:0030027 | lamellipodium | 7.54e-02 | 1.00e+00 | 3.680 | 1 | 7 | 125 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 7.71e-02 | 1.00e+00 | 3.646 | 1 | 11 | 128 |
GO:0016055 | Wnt signaling pathway | 8.29e-02 | 1.00e+00 | 3.538 | 1 | 4 | 138 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8.33e-02 | 1.00e+00 | 2.022 | 2 | 41 | 789 |
GO:0045121 | membrane raft | 9.33e-02 | 1.00e+00 | 3.361 | 1 | 3 | 156 |
GO:0046777 | protein autophosphorylation | 9.44e-02 | 1.00e+00 | 3.342 | 1 | 4 | 158 |
GO:0005768 | endosome | 1.01e-01 | 1.00e+00 | 3.245 | 1 | 3 | 169 |
GO:0016607 | nuclear speck | 1.02e-01 | 1.00e+00 | 3.220 | 1 | 12 | 172 |
GO:0005667 | transcription factor complex | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 17 | 175 |
GO:0009897 | external side of plasma membrane | 1.05e-01 | 1.00e+00 | 3.179 | 1 | 3 | 177 |
GO:0004672 | protein kinase activity | 1.05e-01 | 1.00e+00 | 3.179 | 1 | 3 | 177 |
GO:0031625 | ubiquitin protein ligase binding | 1.06e-01 | 1.00e+00 | 3.170 | 1 | 5 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 22 | 184 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.12e-01 | 1.00e+00 | 3.084 | 1 | 5 | 189 |
GO:0001525 | angiogenesis | 1.13e-01 | 1.00e+00 | 3.069 | 1 | 7 | 191 |
GO:0030168 | platelet activation | 1.21e-01 | 1.00e+00 | 2.967 | 1 | 6 | 205 |
GO:0003713 | transcription coactivator activity | 1.39e-01 | 1.00e+00 | 2.757 | 1 | 24 | 237 |
GO:0000166 | nucleotide binding | 1.51e-01 | 1.00e+00 | 2.629 | 1 | 13 | 259 |
GO:0006954 | inflammatory response | 1.60e-01 | 1.00e+00 | 2.532 | 1 | 6 | 277 |
GO:0006955 | immune response | 1.66e-01 | 1.00e+00 | 2.476 | 1 | 1 | 288 |
GO:0005856 | cytoskeleton | 1.68e-01 | 1.00e+00 | 2.461 | 1 | 9 | 291 |
GO:0043234 | protein complex | 1.70e-01 | 1.00e+00 | 2.442 | 1 | 11 | 295 |
GO:0004674 | protein serine/threonine kinase activity | 1.77e-01 | 1.00e+00 | 2.379 | 1 | 6 | 308 |
GO:0005524 | ATP binding | 1.91e-01 | 1.00e+00 | 1.304 | 2 | 31 | 1298 |
GO:0015031 | protein transport | 1.94e-01 | 1.00e+00 | 2.233 | 1 | 11 | 341 |
GO:0005925 | focal adhesion | 2.07e-01 | 1.00e+00 | 2.130 | 1 | 9 | 366 |
GO:0007155 | cell adhesion | 2.08e-01 | 1.00e+00 | 2.119 | 1 | 5 | 369 |
GO:0005886 | plasma membrane | 2.08e-01 | 1.00e+00 | 0.897 | 3 | 49 | 2582 |
GO:0046982 | protein heterodimerization activity | 2.14e-01 | 1.00e+00 | 2.076 | 1 | 8 | 380 |
GO:0009986 | cell surface | 2.25e-01 | 1.00e+00 | 1.995 | 1 | 9 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.30e-01 | 1.00e+00 | 1.956 | 1 | 24 | 413 |
GO:0007596 | blood coagulation | 2.51e-01 | 1.00e+00 | 1.816 | 1 | 11 | 455 |
GO:0006468 | protein phosphorylation | 2.53e-01 | 1.00e+00 | 1.801 | 1 | 10 | 460 |
GO:0044267 | cellular protein metabolic process | 2.60e-01 | 1.00e+00 | 1.757 | 1 | 20 | 474 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.62e-01 | 1.00e+00 | 1.745 | 1 | 24 | 478 |
GO:0048471 | perinuclear region of cytoplasm | 2.73e-01 | 1.00e+00 | 1.675 | 1 | 8 | 502 |
GO:0016020 | membrane | 2.83e-01 | 1.00e+00 | 0.931 | 2 | 46 | 1681 |
GO:0016032 | viral process | 2.88e-01 | 1.00e+00 | 1.585 | 1 | 26 | 534 |
GO:0005887 | integral component of plasma membrane | 4.36e-01 | 1.00e+00 | 0.852 | 1 | 10 | 888 |
GO:0007165 | signal transduction | 4.43e-01 | 1.00e+00 | 0.821 | 1 | 13 | 907 |
GO:0008270 | zinc ion binding | 4.75e-01 | 1.00e+00 | 0.685 | 1 | 27 | 997 |
GO:0005730 | nucleolus | 6.63e-01 | 1.00e+00 | -0.034 | 1 | 66 | 1641 |
GO:0070062 | extracellular vesicular exosome | 8.06e-01 | 1.00e+00 | -0.583 | 1 | 57 | 2400 |